January 4, 2018 / 11:19 AM / 9 months ago

BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan

Jan 4 (Reuters) - Nanostring Technologies Inc:

* NANOSTRING AND RIKENGENESIS ANNOUNCE PARTNERSHIP TO COMMERCIALIZE NCOUNTER-BASED DIAGNOSTIC ASSAYS IN JAPAN

* NANOSTRING -‍ UNDER AGREEMENT, CO, RIKEN GENESIS TO COLLABORATE TO REGISTER, OBTAIN REIMBURSEMENT, COMMERCIALIZE COMPANION DIAGNOSTIC ASSAYS IN JAPAN​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below